# Open-label Trial of IVIG in Children With PANS

> **NCT04609761** · PHASE2 · COMPLETED · sponsor: **Göteborg University** · enrollment: 17 (actual)

## Conditions studied

- PANS Pediatric Acute-Onset Neuropsychiatric Syndrome

## Interventions

- **DRUG:** Privigen Injectable Product (Intravenous Immunoglobulin)

## Key facts

- **NCT ID:** NCT04609761
- **Lead sponsor:** Göteborg University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-01-12
- **Primary completion:** 2025-10-15
- **Final completion:** 2025-10-15
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2026-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04609761

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04609761, "Open-label Trial of IVIG in Children With PANS". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04609761. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*